文献速递腹部CT

CT体成分预测胰腺癌无效 upfront 切除:多中心研究

CT-derived body composition predicts futile upfront resection in pancreatic cancer: a multicenter study.
PubMed 文献 · Eur Radiol · 2026-05-28

该多中心回顾性研究纳入604例解剖可切除胰腺导管腺癌患者,基于术前CT第三腰椎水平骨骼肌和脂肪组织分割得出体成分指标,构建无效 upfront 切除(术后6个月内死亡或复发)风险模型。模型包含CA19-9、CT肿瘤大小和SMI分类,验证队列AUC为0.750,且与总生存独立相关。

要点

  • 术前CT测量L3水平SMI并分类,可辅助预测胰腺癌 upfront 切除后6个月内死亡或复发风险。
  • SMI分类、CT肿瘤大小和CA19-9共同构成无效切除风险模型,验证AUC为0.750。
  • 该模型有助于在 upfront 手术与新辅助治疗之间进行决策参考。

关键影像表现/征象

  • 从术前CT第三腰椎水平的骨骼肌和脂肪组织分割得出骨骼肌指数、偏离性别特异性肌少症阈值的程度及内脏脂肪相关比值等体成分指标。
  • 无效胰腺切除术定义为术后6个月内死亡或复发,发生率为20.2%。

诊断标准与关键数值

  • 无效切除风险模型由CA19-9、CT肿瘤大小和SMI分类(基于相对偏离性别特异性肌少症阈值的程度定义)构成。
  • 验证队列中模型预测无效胰腺切除术的AUC为0.750(95%CI 0.665-0.834)。
  • 模型与术后总生存独立相关(HR 1.53,95%CI 1.33-1.77,p<0.001),校正病理预测因素后仍显著。

临床应用与阅片要点

  • 阅片时可利用术前CT在第三腰椎水平评估骨骼肌指数并判断SMI分类,结合肿瘤大小和CA19-9辅助识别无效切除高风险患者。
  • 该模型可为胰腺癌治疗顺序选择(upfront手术 vs 新辅助治疗)提供术前参考信息。

局限性

  • 回顾性研究设计。
  • 无效胰腺切除术定义为术后6个月内死亡或复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the utility of CT-derived body composition in predicting futile pancreatectomy and to develop a risk-stratification model for patients with pancreatic ductal adenocarcinoma (PDAC).

MATERIALS AND METHODS: Patients with anatomically resectable PDAC who underwent upfront pancreatectomy between March 2015 and November 2024 at three institutions were retrospectively included. Futile pancreatectomy was defined as death or recurrence within 6 months postoperatively. Body composition metrics were derived from skeletal muscle and adipose tissue segmented at the third lumbar level on preoperative CT, including the skeletal muscle index (SMI), deviation from sex-specific sarcopenia thresholds, and visceral fat-related ratios. A futility risk model was developed and validated using multivariable logistic regression, and its prognostic association with overall survival (OS) was assessed using Cox regression.

RESULTS: A total of 604 patients (median age, 67.0 years [interquartile range, 60.0-72.0]; 348 males) were included, comprising 354 in the derivation cohort and 250 in the validation cohort. Futile pancreatectomy occurred in 20.2% of patients. Carbohydrate antigen 19-9, tumor size on CT, and SMI category, defined by relative deviation from sex-specific sarcopenia thresholds, were independent predictors and constituted the proposed futility risk model. In the validation cohort, the model achieved an area under the receiver operating characteristic curve of 0.750 (95% confidence interval (CI): 0.665-0.834) and was independently associated with OS after resection (HR, 1.53; 95% CI, 1.33-1.77; p < 0.001) after adjustment for pathological predictors.

CONCLUSIONS: The proposed model incorporating SMI predicts futile upfront resection in PDAC with moderate discrimination and provides preoperative prognostic information for OS.

KEY POINTS: Question Can CT-derived body composition improve preoperative identification of patients with resectable pancreatic ductal adenocarcinoma who are at high risk of futile upfront pancreatectomy? Findings A model integrating CT-derived skeletal muscle index category, tumor size, and CA 19-9 achieved good discrimination for futile pancreatectomy and independently predicted overall survival. Clinical relevance By incorporating CT-derived skeletal muscle index category as an important patient-related factor, the proposed model for futile resection improves predictive performance and may help inform treatment sequencing between upfront surgery and neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Dai GX, Zhou Y, Zhang QB, et al. CT-derived body composition predicts futile upfront resection in pancreatic cancer: a multicenter study. Eur Radiol. 2026. PMID: 42209831. doi:10.1007/s00330-026-12643-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。